WACOG Meeting post ENETs Meeting

On the 28th of April,  the Western Australian Clinical Oncology (WACOG) held its  “Post-ENETs” meeting at the University of Western Australia.

This meeting focussed on – Combination and Sequencing of NET Therapy

CONTROL-NETs RCT vs Current US/EU NETs Studies

Prof J Harvey Turner – Fiona Stanley Hospital

Patient Reported Outcomes & Quality of Life Amongst NET Patients

– Dr John C Leyden –  FANZCA, President, Unicorn Foundation

– Dr Sam Vohra, PhD – Scientific Manager, Medical Department, Ipsen Pty Ltd

– Dr Vanessa Sequeira, PhD – Medical Advisor, Novartis

During the short stay, Dr Leyden met with local NET patients and NET medical Specialists and discussed the formation of a Perth based Unicorn Foundation patient support group. The Unicorn Foundation is committed to increasing engagement with our Western Australian NET patients and the extended NET community to help increase awareness, education, patients support and to help improve clinical outcomes for all WA NET patients.

wa1 

The Unicorn Foundation is extremely grateful for the enthusiasm, commitment and leadership shown by Prof Harvey Turner and other members of WACOG who manage and treat our NET patients and we look forward to building a strong presence in the West.

wa3 

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.